Back
59
Day Range
$70.61
$72.46
52-Week Range
$58.35
$85.15
Volume
6,601,139
50D / 200D Avg
$77.57
/
$74.12
Prev Close
$71.48
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 51.3 | 0.4 |
| P/B | 1.2 | 2.9 |
| ROE % | 2.4 | 3.8 |
| Net Margin % | 0.4 | 3.9 |
| Rev Growth 5Y % | 8.3 | 10.0 |
| D/E | 1.2 | 0.2 |
Analyst Price Target
Hold
$95.15
+33.5%
Low: $90.00
High: $103.00
Forward P/E
10.0
Forward EPS
$7.17
EPS Growth (est.)
+0.0%
Est. Revenue
410 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$11.47
$10.95 – $12.14
|
500 B | 4 |
| FY2029 |
$10.47
$10.00 – $11.08
|
480 B | 4 |
| FY2028 |
$9.41
$8.57 – $11.16
|
450 B | 10 |
Key Takeaways
Revenue grew 8.31% annually over 5 years — modest growth
Earnings declined -61.68% over the past year
ROE of 2.35% is below average
Generating 7.81B in free cash flow
P/E of 51.30 — premium valuation
Cash machine — converts 441.57% of earnings into free cash flow
Growth
Revenue Growth (5Y)
8.31%
Revenue (1Y)7.85%
Earnings (1Y)-61.68%
FCF Growth (3Y)-13.34%
Quality
Return on Equity
2.35%
ROIC4.61%
Net Margin0.44%
Op. Margin2.58%
Safety
Debt / Equity
1.24
Current Ratio0.84
Interest Coverage3.33
Valuation
P/E Ratio
51.30
P/B Ratio1.21
EV/EBITDA16.93
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.85% | Revenue Growth (3Y) | 6.01% |
| Earnings Growth (1Y) | -61.68% | Earnings Growth (3Y) | -53.97% |
| Revenue Growth (5Y) | 8.31% | Earnings Growth (5Y) | -31.44% |
| Profitability | |||
| Revenue (TTM) | 402.07B | Net Income (TTM) | 1.77B |
| ROE | 2.35% | ROA | 0.68% |
| Gross Margin | 13.77% | Operating Margin | 2.58% |
| Net Margin | 0.44% | Free Cash Flow (TTM) | 7.81B |
| ROIC | 4.61% | FCF Growth (3Y) | -13.34% |
| Safety | |||
| Debt / Equity | 1.24 | Current Ratio | 0.84 |
| Interest Coverage | 3.33 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 51.30 | P/B Ratio | 1.21 |
| P/S Ratio | 0.23 | PEG Ratio | -0.92 |
| EV/EBITDA | 16.93 | Dividend Yield | 0.03% |
| Market Cap | 90.70B | Enterprise Value | 175.78B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 402.07B | 372.81B | 357.78B | 322.47B | 292.11B |
| Net Income | 1.77B | 4.61B | 8.34B | 4.31B | 8.00B |
| EPS (Diluted) | 1.39 | 3.66 | 6.47 | 3.26 | 5.95 |
| Gross Profit | 55.36B | 51.40B | 54.43B | 54.50B | 52.12B |
| Operating Income | 10.39B | 8.52B | 13.74B | 7.95B | 13.31B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 261.06B | 253.22B | 249.73B | 228.28B | 233.00B |
| Total Liabilities | 185.68B | 177.49B | 173.09B | 156.51B | 157.62B |
| Shareholders' Equity | 75.21B | 75.56B | 76.46B | 71.47B | 75.08B |
| Total Debt | 93.59B | 82.92B | 79.39B | 70.73B | 76.00B |
| Cash & Equivalents | 8.51B | 8.59B | 8.20B | 12.95B | 9.41B |
| Current Assets | 74.71B | 68.65B | 67.86B | 65.63B | 60.01B |
| Current Liabilities | 88.69B | 84.61B | 79.19B | 69.42B | 67.81B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#223 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026